Fabienne Piras-Douce

Title: Fabienne Piras-Douce: Innovator in Immunogenic Composition

Introduction

Fabienne Piras-Douce is a notable inventor based in Fleurieux sur l'Arbresle, France. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human cytomegalovirus (HCMV). With a total of 2 patents, her work is paving the way for advancements in vaccine technology.

Latest Patents

Her latest patents focus on immunogenic compositions that include HCMV antigens. The first patent describes an immunogenic composition comprising an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen, and a Th1-inducing adjuvant. This composition is intended for use as an HCMV vaccine. The second patent also relates to an immunogenic composition that includes the HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant, further emphasizing its application as an HCMV vaccine.

Career Highlights

Fabienne Piras-Douce is currently associated with Sanofi Pasteur Inc., a leading company in the field of vaccines. Her work at Sanofi Pasteur has allowed her to focus on innovative solutions to combat viral infections, particularly HCMV.

Collaborations

Throughout her career, Fabienne has collaborated with talented professionals such as Pascal Chaux and Rafaela Dumas. These collaborations have enriched her research and contributed to the success of her inventions.

Conclusion

Fabienne Piras-Douce is a pioneering inventor whose work in immunogenic compositions is making a significant impact in the field of vaccine development. Her contributions are essential in the fight against human cytomegalovirus, showcasing her dedication to advancing medical science.